Alcohol and Substance Abuse in Solid-Organ Transplant Recipients

被引:48
|
作者
Parker, Richard [1 ,2 ,3 ]
Armstrong, Matthew J. [1 ,2 ,3 ]
Corbett, Chris [1 ,2 ,3 ]
Day, Edward J. [4 ]
Neuberger, James M. [3 ,5 ]
机构
[1] Univ Birmingham, Natl Inst Hlth Res Biomed Res Unit, Birmingham B15 2TT, W Midlands, England
[2] Univ Birmingham, Liver Res Ctr, Birmingham B15 2TT, W Midlands, England
[3] Univ Hosp Birmingham NHS Fdn Trust, Liver Unit, Birmingham, W Midlands, England
[4] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England
[5] NHS Blood & Transplant, Bristol, Avon, England
基金
英国惠康基金; 英国医学研究理事会;
关键词
Alcohol; Drugs; Substance abuse; Transplantation; ORTHOTOPIC LIVER-TRANSPLANTATION; CARBOHYDRATE-DEFICIENT TRANSFERRIN; LONG-TERM GRAFT; ETHYL GLUCURONIDE; FOLLOW-UP; PSYCHOSOCIAL EVALUATION; INTERNATIONAL-SOCIETY; HEART-TRANSPLANTATION; LABORATORY MARKERS; SCREENING-TEST;
D O I
10.1097/TP.0b013e31829f7579
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This review focuses on alcohol and substance abuse in the context of solid-organ transplantation. Alcohol and substance abuse are common and may lead to a need for solid-organ transplantation and may also contribute to significant physical and psychologic problems that impact upon the recipient. Damaging levels of alcohol intake can occur in the absence of dependence. Alcohol or substance abuse after transplantation is associated with poor medication compliance and this may increase risk of graft loss. Intravenous drug use is associated with increased risk of infections (especially secondary to opportunistic organisms-bacterial, viral, protozoal, and others-and such infections may be more severe in the immunosuppressed), but there is only anecdotal evidence that such behavior has a worse outcome in transplant recipients. Whereas previous alcohol excess and drug use in kidney recipients are both associated with a small but statistically significantly increased risk of adverse outcomes (hazard ratio, 1.16-1.56), alcohol use within recommended guidelines after transplantation appears safe and possibly beneficial. Robust data are lacking for other organs, but those available suggest that heart transplantation is safe in individuals with a history of alcohol or substance abuse. Health specialists in drug or alcohol addiction should carefully screen all potential transplant candidates for these conditions, and where there is evidence of dependency or abuse, effective psychologic and physical treatment should be offered. Studies have shown that interventions such as psychologic intervention have improved alcohol behavior in the context of liver transplantation. Although there are no comparable studies with other solid-organ recipients, it is reasonable to expect transferable outcomes.
引用
收藏
页码:1015 / 1024
页数:10
相关论文
共 50 条
  • [31] Pharmacokinetics of Intravenous Isavuconazole in Solid-Organ Transplant Recipients
    Wu, Xuemei
    Clancy, Cornelius J.
    Rivosecchi, Ryan M.
    Zhao, Wenchen
    Shields, Ryan K.
    Marini, Rachel V.
    Venkataramanan, Raman
    Nguyen, M. Hong
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (12)
  • [32] RECURRENT CYTOMEGALOVIRUS DISEASE IN SOLID-ORGAN TRANSPLANT RECIPIENTS
    FALAGAS, ME
    SNYDMAN, DR
    TRANSPLANTATION PROCEEDINGS, 1995, 27 (05) : 34 - 37
  • [33] Colorectal cancer among solid-organ transplant recipients
    Johnson, E
    Pirsch, J
    Heise, C
    GASTROENTEROLOGY, 2005, 128 (04) : A798 - A799
  • [34] Management of cytomegalovirus infection in solid-organ transplant recipients
    Murray, BM
    IMMUNOLOGICAL INVESTIGATIONS, 1997, 26 (1-2) : 243 - 255
  • [35] Cardiac operations in solid-organ transplant recipients - Discussion
    Bolman, RM
    Mitruka
    ANNALS OF THORACIC SURGERY, 1997, 64 (05): : 1278 - 1278
  • [36] A Review of the Prevalence of Illicit Substance Use in Solid-Organ Transplant Candidates and the Effects of Illicit Substance Use on Solid-Organ Transplant Treatment Outcomes
    Majumder, Pradipta
    Sarkar, Siddharth
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (07)
  • [37] Antimicrobial stewardship programs in solid-organ transplant recipients in Switzerland
    Bielicki, Julia A.
    Manuel, Oriol
    TRANSPLANT INFECTIOUS DISEASE, 2022, 24 (05)
  • [38] Longitudinal study of cryptococcosis in adult solid-organ transplant recipients
    Vilchez, R
    Shapiro, R
    McCurry, K
    Kormos, R
    Abu-Elmagd, K
    Fung, J
    Kusne, S
    TRANSPLANT INTERNATIONAL, 2003, 16 (05) : 336 - 340
  • [39] Viral Hepatitis Recommendations for Solid-Organ Transplant Recipients and Donors
    Faria, Luciana Costa
    Benedita Terrabuio, Debora Raquel
    Leblebicioglu, Hakan
    Huprikar, Shirish
    TRANSPLANTATION, 2018, 102 (02) : S66 - S71
  • [40] Chagas Disease Recommendations for Solid-Organ Transplant Recipients and Donors
    Pierrotti, Ligia Camera
    Carvalho, Noemia Barbosa
    Amorin, Jimena Prieto
    Pascual, Julio
    Kotton, Camille N.
    Lopez-Velez, Rogelio
    TRANSPLANTATION, 2018, 102 (02) : S1 - S7